Conventional pseudophakic monovision--visual function, patient satisfaction and complications.

PURPOSE: To evaluate visual function, patient satisfaction and complications after cataract surgery with conventional pseudophakic monovision in a 3-month follow-up. METHODS: The following parameters were evaluated in a group of 20 selected patients (40 eyes) mean age: 62.15 +/- 7.22 years, who underwent bilateral cataract surgery with monofocal lens implantation (Alcon SA60AT) in the conventional monovision procedure 3 months earlier (target refraction: dominant eye-emmetropia, fellow eye--2.0 D): binocular uncorrected visual acuity for near, intermediate distance and distance (logMAR), contrast sensitivity (CS-CSV-1000), spectacle independence, patient satisfaction (Type Q) and complication rate. RESULTS: The mean prescription for distance was in -0.01 +/- 0.14 D in dominant eyes, and -1.85 +/- 0.19 D for near in nondominant eyes. Three months after surgery, patients had a very good binocular distance, near as well as intermediate visual acuities (-0.03 +/- 0.09, -0.1 +/- 0.11, and -0.39 +/- 0.17, respectively). Binocular contrast sensitivity values under mesopic and photopic conditions for distance and under photopic conditions for near fell in the reference range for age. Most patients (80%) did not require any additional correction. Spectacle independence for distance, near and intermediate distances was 100%, 80% and 90%, respectively. General patient satisfaction was very high (9.40/10). There were no postoperative complications. CONCLUSIONS: Cataract surgery with monofocal lens implantation during a conventional monovision procedure (E,-2.0 D) in a selected group of patients offered a very good binocular visual function, a substantial spectacle independence and overall patient satisfaction. pseudophakic monovision, visual function, patient satisfaction, complications.

[Primary intraocular lymphoma--2.5 year follow-up]. / Pierwotny chloniak wewnatrzgalkowy--opis pacjenta w obserwacji 2,5-letniej.

PURPOSE: To present clinical manifestation, diagnosis and treatment of a patient with the primary intraocular lymphoma at 2.5 year follow-up. PATIENT AND METHODS: Phaco-PPV with silicone oil tamponade was performed in a 62 year old man with a diagnosis of recurrent bilateral uveitis of unknown etiology complicated by cataract. The creamy-yellow infiltrates were identified and aspirates were collected for immunocytochemical evaluation during the surgery--B-cell lymphoma was diagnosed. The results of additional tests--hematologic workup, head and orbit neuro-imaging--were within normal limits. The patient has been treated with regular intraocular injections of Methotrexate at a dose of 400 microg/0.1 ml to both eyes for 2.5 years. Regular routine ophtalmic examinations were performed during the said follow-up period. RESULTS: The lymphocyte infiltrations in both eyes regressed during therapy. The best corrected distance VA remained stable and was 0.2 in RE and 0.3 in LE (Snellen). The intraocular pressures and anterior segments in both eyes were normal. The new small lymphocyte infiltrates were observed in the fundi and were successfully treated with additional Methotrexate injections. Methotrexate treatment was augmented with a single laser endophotocoagulation in the LE and 2, 3-time argon laser photocagulation in both eyes. To date, there no systemic symptoms of the disease have been observed. CONCLUSIONS: Local chemotherapy with Methotrexate may be an effective and safe treatment of primary intraocular lymphoma. However, due to high potential for systemic and local spread, patients should be monitored on a regular basis by ophthalmologists and oncologists.